Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery

Frontiers in Cellular and Infection Microbiology(2022)10.3389/fcimb.2022.974101Source: DataRank Database

How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery is a research paper published in Frontiers in Cellular and Infection Microbiology (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: goldTopics (26)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Aditi Deshpande ORCID,Tanya Parish ORCID,Amala Bhagwat ORCID

Live enrichment

PubMed:36159638 PMC:PMC9500310 OpenAlex:https://openalex.org/W36159638

NIAID NIH HHS

Grant: R01 AI129360

National Institutes of Health

Grant: 5R01AI129360-05

The role of Esx-3 in mediating drug resistance

National Institute of Allergy and Infectious Diseases

Congressionally Directed Medical Research Programs

FWCI

0.00

Citation Percentile

0.0%

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fcimb.2022.974101/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fcimb.2022.974101/full

journalhttps://dialnet.unirioja.es/servlet/articulo?codigo=2379617

repositoryhttps://doaj.org/article/6657a959d46b4a57a1319145f9823b04

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9500310

Fields of Study

Historical Studies on SpainHistorical Art and Architecture StudiesMedieval and Early Modern Iberia0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansMycobacterium tuberculosisTuberculosis, Lymph NodeAntitubercular AgentsDrug ResistanceDrug Discovery

Keywords

HumanitiesArtMycobacterium tuberculosisAntibacterialAntibiotic Resistancedrug discoveryAntibiotic ToleranceAntitubercular AgentsDrug ResistanceTuberculosis, Lymph NodeMicrobiologyQR1-502Cellular and Infection MicrobiologyHumans

Sustainable Development Goals

SDG 3: 3. Good health